To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function
Clinical trial NCT05404542 · COMPLETED
Trial details
- NCT number
- NCT05404542
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-10
- Primary completion
- 2023-08-14
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.